NSE Code – PERSISTENT
View – Bullish
Last Close – Rs 652.65
View – Bullish
Last Close – Rs 742.25
Justification – After a long underperformance, the Pharma space is now on the path of revival. On the daily chart, after a recent sharp bounce from the levels of 646 to the recent high of 787, the prices have witnessed a price-wise correction. The said correction is forming a base around 50 per cent retracement of the above rally and price structure suggests a resumption of up move very soon. The lead indicator RSI after taking support at 40 levels has turned northward signaling a fresh buy with its smoothened moving average supporting the preemptive buy call. In addition, prices are trading well above 20SMA and 50SMA which indicates short to medium term bullishness. Hence, we recommend buying this stock at current levels for a target of Rs.798 over the next few weeks. The stop loss should be fixed at Rs.710.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)